146 related articles for article (PubMed ID: 8994315)
1. In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid.
Gupta RK; Chang AC; Griffin P; Rivera R; Siber GR
Vaccine; 1996 Oct; 14(15):1412-6. PubMed ID: 8994315
[TBL] [Abstract][Full Text] [Related]
2. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
[TBL] [Abstract][Full Text] [Related]
3. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
Gupta RK; Griffin P; Rivera R; Siber GR
Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
[TBL] [Abstract][Full Text] [Related]
4. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice.
Jung T; Koneberg R; Hungerer KD; Kissel T
Int J Pharm; 2002 Mar; 234(1-2):75-90. PubMed ID: 11839439
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.
Eldridge JH; Staas JK; Meulbroek JA; Tice TR; Gilley RM
Infect Immun; 1991 Sep; 59(9):2978-86. PubMed ID: 1879922
[TBL] [Abstract][Full Text] [Related]
6. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
Sánchez A; Villamayor B; Guo Y; McIver J; Alonso MJ
Int J Pharm; 1999 Aug; 185(2):255-66. PubMed ID: 10460920
[TBL] [Abstract][Full Text] [Related]
7. A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle.
Tobío M; Nolley J; Guo Y; McIver J; Alonso MJ
Pharm Res; 1999 May; 16(5):682-8. PubMed ID: 10350011
[TBL] [Abstract][Full Text] [Related]
8. Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid.
Raghuvanshi RJ; Mistra A; Talwar GP; Levy RJ; Labhasetwar V
J Microencapsul; 2001; 18(6):723-32. PubMed ID: 11695637
[TBL] [Abstract][Full Text] [Related]
9. Improved immunogenicity of a core-coated tetanus toxoid delivery system.
Tobío M; Schwendeman SP; Guo Y; McIver J; Langer R; Alonso MJ
Vaccine; 1999 Nov; 18(7-8):618-22. PubMed ID: 10547420
[TBL] [Abstract][Full Text] [Related]
10. Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents.
Audran R; Men Y; Johansen P; Gander B; Corradin G
Pharm Res; 1998 Jul; 15(7):1111-6. PubMed ID: 9688068
[TBL] [Abstract][Full Text] [Related]
11. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice.
Jung T; Kamm W; Breitenbach A; Hungerer KD; Hundt E; Kissel T
Pharm Res; 2001 Mar; 18(3):352-60. PubMed ID: 11442276
[TBL] [Abstract][Full Text] [Related]
12. Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres.
Men Y; Gander B; Merkle HP; Corradin G
Vaccine; 1996 Oct; 14(15):1442-50. PubMed ID: 8994320
[TBL] [Abstract][Full Text] [Related]
13. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
14. Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine.
Schwendeman SP; Costantino HR; Gupta RK; Tobio M; Chang AC; Alonso MJ; Siber GR; Langer R
Dev Biol Stand; 1996; 87():293-306. PubMed ID: 8854030
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine.
Singh M; Li XM; Wang H; McGee JP; Zamb T; Koff W; Wang CY; O'Hagan DT
Infect Immun; 1997 May; 65(5):1716-21. PubMed ID: 9125552
[TBL] [Abstract][Full Text] [Related]
17. Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs.
Johansen P; Tamber H; Merkle HP; Gander B
Eur J Pharm Biopharm; 1999 May; 47(3):193-201. PubMed ID: 10382103
[TBL] [Abstract][Full Text] [Related]
18. Determinants of release rate of tetanus vaccine from polyester microspheres.
Alonso MJ; Cohen S; Park TG; Gupta RK; Siber GR; Langer R
Pharm Res; 1993 Jul; 10(7):945-53. PubMed ID: 8378256
[TBL] [Abstract][Full Text] [Related]
19. Poly (D,L-lactide) glycolide polymer microsphere entrapped tetanus toxoid: safety evaluation in Wistar rats.
Chaudhury MR; Sharma K; Giri DK
Hum Exp Toxicol; 1996 Mar; 15(3):205-7. PubMed ID: 8839206
[TBL] [Abstract][Full Text] [Related]
20. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.
Raghuvanshi RS; Katare YK; Lalwani K; Ali MM; Singh O; Panda AK
Int J Pharm; 2002 Oct; 245(1-2):109-21. PubMed ID: 12270248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]